TY  - CONF

T1  - Fifty-two-week laboratory safety findings from an open-label extension study of dupilumab in adolescent patients with atopic dermatitis (LIBERTY AD PED-OLE)

JO  - BRITISH JOURNAL OF DERMATOLOGY

PY  - 2021/01/01

AU  - Cork MJ

AU  - Lockshin B

AU  - Blauvelt A

AU  - Chen Z

AU  - Vakil J

AU  - Khokhar FA

ED  - 

VL  - 185

IS  - 3

SP  - E121

EP  - E121

Y2  - 2024/12/22

ER  -